ID: ALA3228401

Max Phase: Preclinical

Molecular Formula: C5H8BrN3

Molecular Weight: 109.13

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Br.Cn1ccncc1=N

Standard InChI:  InChI=1S/C5H7N3.BrH/c1-8-3-2-7-4-5(8)6;/h2-4,6H,1H3;1H

Standard InChI Key:  SSLUIWIGJCDQSA-UHFFFAOYSA-N

Associated Targets(non-human)

INMT Indolethylamine N-methyltransferase (82 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 109.13Molecular Weight (Monoisotopic): 109.0640AlogP: -0.10#Rotatable Bonds: 0
Polar Surface Area: 41.67Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.99CX LogP: 0.09CX LogD: -2.10
Aromatic Rings: 1Heavy Atoms: 8QED Weighted: 0.50Np Likeness Score: -1.13

References

1. Rokach J, Hamel P, Hunter NR, Reader G, Rooney CS, Anderson PS, Cragoe EJ, Mandel LR..  (1979)  Cyclic amidine inhibitors of indolamine N-methyltransferase.,  22  (3): [PMID:423205] [10.1021/jm00189a004]

Source